Dr. Mackenzie Carpenter Cervenka, MD

Dr. Cervenka practices at Privia Medical Group in Gaithersburg, Maryland.

Dr. Cervenka's NPI, 1407981699, was assigned on February 21, 2007. Dr. Cervenka graduated from University of Virginia School of Medicine in 2004. Dr. Cervenka holds Maryland license D67856.

Dr. Cervenka's primary practice is Privia Medical Group, at 203 Perry Pkwy, Gaithersburg, MD 20877 in Montgomery County. The practice phone is (571) 366-8850.

Dr. Cervenka's primary practice is Privia Medical Group in Gaithersburg, Maryland. Dr. Cervenka is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Cervenka to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cervenka practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cervenka's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cervenka is licensed in Maryland.

CMS data shows 976 Medicare services from Dr. Cervenka across 13 procedure codes in 2024, for 190 Medicare patients. Medicare paid $39,183 for them.

CMS counts 190 Medicare patients who saw Dr. Cervenka in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cervenka's median patient age at 41, with 59% women.

In 2024, Dr. Cervenka wrote 625 Medicare Part D claims for 55 patients. 69% of them were for generic drugs. CMS names the drug for 535 of them, across 16 drugs with 11 or more claims each, at $541,961 in total drug cost. In 2023, CMS named 528 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Cervenka for performance year 2024, reported as part of a group. CMS lists Dr. Cervenka as offering telehealth.

Dmand AI links 78 papers to Dr. Cervenka, published from 2011 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Epilepsy, Diet, Ketogenic and Electroencephalography. Dr. Cervenka has published most often in Epilepsy Behav. Dr. Cervenka's most frequent co-authors are Tanya Joelle Williams McDonald, MD, Nathan Earl Crone, MD and Elizabeth Ann Felton, MD.

Dmand AI links Dr. Cervenka to 2 clinical trials. Conditions studied include Seizures, Status Epilepticus and Epilepsy. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 5 general payments to Dr. Cervenka from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. LivaNova PLC paid the most, $148.

Dr. Cervenka graduated from University of Virginia School of Medicine in 2004.